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Vagal control of the heart 
decreases during increasing 
imminence of interoceptive threat 
in patients with panic disorder 
and agoraphobia
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Georg W. Alpers11, Sylvia Helbig‑Lang12, Jürgen Deckert13, Thomas Fydrich14, Lydia Fehm14, 
Andreas Ströhle15, Tilo Kircher16, Volker Arolt17 & Alfons O. Hamm1 
Theoretically, panic disorder and agoraphobia pathology can be conceptualized as a cascade of 
dynamically changing defensive responses to threat cues from inside the body. Guided by this trans‑
diagnostic model we tested the interaction between defensive activation and vagal control as a 
marker of prefrontal inhibition of subcortical defensive activation. We investigated ultra‑short‑term 
changes of vagally controlled high frequency heart rate variability (HRV) during a standardized threat 
challenge (entrapment) in n = 232 patients with panic disorder and agoraphobia, and its interaction 
with various indices of defensive activation. We found a strong inverse relationship between HRV and 
heart rate during threat, which was stronger at the beginning of exposure. Patients with a strong 
increase in heart rate showed a deactivation of prefrontal vagal control while patients showing 
less heart rate acceleration showed an increase in vagal control. Moreover, vagal control collapsed 
in case of imminent threat, i.e., when body symptoms increase and seem to get out of control. In 
these cases of defensive action patients either fled from the situation or experienced a panic attack. 
Active avoidance, panic attacks, and increased sympathetic arousal are associated with an inability 
to maintain vagal control over the heart suggesting that teaching such regulation strategies during 
exposure treatment might be helpful to keep prefrontal control, particularly during the transition zone 
from post‑encounter to circa strike defense.
Trial Registration Number: ISRCTN80046034.
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Panic attacks are defined as abrupt surges of intense fear that reach a peak within minutes during which four (or 
more) symptoms from a list of 13 symptoms occur (DSM-5)1. If such panic attacks are followed by persistent 
concerns about additional panic attacks or their consequences, a panic disorder is diagnosed. Most panic attacks 
are experienced during the day (85%) and outside the home (73%), thus, occurring in contexts that are typical 
for agoraphobic  situations2,3 and, as a consequence, are often associated with agoraphobic avoidance.
Theoretically, panic attacks, anxious apprehension, and agoraphobic avoidance might be conceptualized as a 
dynamically organized cascade of defensive responses that vary systematically as a function of increasing prox-
imity of  threat4–7. When an organism enters a context in which a threat has been encountered previously but has 
not yet been detected, a class of adaptive behaviors is engaged, including increased vigilance, autonomic arousal 
and inhibition of appetitive behaviors. As soon as the threat is detected but is still distant, increased selective 
attentive freezing is evoked by the threatening cue. When the threat is coming closer, defensive actions such as 
fight or flight are  mobilized8–11. In the case of panic disorder and agoraphobia, the survival-relevant threat, how-
ever, does not arise from external sources (e.g., a predator) but from inside the body. Potentially life threatening 
interoceptive challenges, such as cardiac arrhythmias or hypoxia, are among the primary symptoms of panic 
 attacks12,13. Thus, defensive responses do not vary as a function of spatial distance and temporal proximity of 
exteroceptive threat cues. Instead the intensity and number of painful and non-painful interoceptive sensations 
often in combination with a perceived lack of control determine the defensive action evoked by interoceptive 
 threat6,14. Consequently, acute panic attacks can be considered as instances of circa strike  defense5,6 to intense 
interoceptive symptoms that seem to get out of control evoking feelings of extreme fear. These feelings are thought 
to be associated with a strong discharge of the sympathetic nervous  system15, and the urge to  escape16. Perception 
of mild bodily symptoms, often interpreted as precursors of an upcoming panic attack, evoke increased selec-
tive attention to such bodily symptoms and are associated with a potentiation of the startle reflex as an index of 
defensive  freezing17–19 associated with post-encounter  defense6.
The human brain comprises numerous networks to ensure the detection and discrimination of interoceptive 
signals that indicate danger for the body´s integrity and organize adaptive defensive  responses20–22 including the 
internal regulation of visceromotor adaptations as described in the neurovisceral integration model (NIM) by 
Thayer and  Lane23,24. According to this model, afferent information from all organs of the body are transmitted 
via afferent fibers of the vagus that terminate in the nucleus tractus solitaries (NTS). Visceral afferents from the 
heart, the blood vessels, the intestines, and the respiratory tracts that are relevant for detecting panic related 
symptoms terminate in the caudal part of the NTS. From there, information is projected via the central autonomic 
network (CAN)25 to the anterior cingulate, insular, and prefrontal cortex. Accordingly, increased activation in the 
anterior insula and cingulate cortex was found when individuals with high fear of body symptoms were exposed 
to cues previously associated with unpleasant body  symptoms18. In addition to the afferent loop, the CAN is 
comprised of direct and indirect pathways that modulate the preganglionic sympathetic and parasympathetic 
neurons. As suggested in the NIM, the sympathoexcitatory, cardioacceleratory subcortical threat circuits that 
are activated during a panic attack are under tonic inhibitory control via GABA-ergic mediated projections from 
the prefrontal  cortex24,26, which is hypothesized to be deactivated during threat processing. As elaborated in the 
 NIM24 this tonic prefrontal inhibition can be indexed by the cardiac chronotropic control via a vagally mediated 
pathway and can be assessed by high frequency resting heart rate variability (HRV) with higher resting HRV 
being associated with stronger tonic prefrontal inhibition. Accordingly, phasic decreases of HRV reflect adaptive 
decreases of prefrontal control in favor of a more reflexive midbrain processing as observed in stress  studies27.
Guided by this model, we analyzed the dynamics of phasic HRV changes during a potentially threatening con-
text in patients diagnosed with a principal diagnosis of panic disorder with agoraphobia (PD/AG) and enrolled 
for a multicenter randomized controlled clinical  trial28,29. Because marked fear of entrapment and avoidance of 
being in enclosed places is a prominent symptom in patients with PD/AG30,31 we analyzed vagally controlled 
HRV during and after a behavioral avoidance test (BAT; i.e., sitting in a small dark closed test chamber with the 
door locked from outside)14.
We hypothesized increasing deactivation of prefrontal inhibition with increasing imminent threat process-
ing. Hence, we expected strongly decreased HRV during acute states of circa strike defense during the threat 
challenge as compared to a control condition. To test our hypothesis, we analyzed the phasic HRV changes 
during online-recorded panic attacks and prior to escape behavior during the BAT relative to a recovery phase 
after the BAT exposure. Together with decreased prefrontal inhibition and HRV we expected to observe rela-
tively increased cholinergic sympathetic and cardioaccelatory activation during these instances of circa strike 
defense (i.e., immediately prior to escape and panic attacks) as measured by skin conductance level (SCL) and 
heart rates, respectively. Because the standardized exposure to a situation of entrapment provoked defensive 
activations in many but not all PD/AG  patients14 we further hypothesized the BAT non-avoiding patients to 
show HRV changes depending on the intensity of distal threat processing. Following the aims of the Research 
Domain Criteria (RDoC)  perspective32, we thereby used the phasic heart change during the exposure relative 
to the control condition to rank our non-avoiding patients into five groups (quintiles) of equal size along a dis-
tribution ordered by this autonomic reactivity measure of defensive mobilization. We expected that prefrontal 
inhibition would be deactivated as a function of threat proximity and, as a result, vagally mediated HRV would 
decrease with increasing heart rate. Because those non-avoiding patients managed to remain in this situation, 
we expected the HRV to increase during the BAT in high heart rate reactive patients (post-encounter defense) 
suggesting a recovery of prefrontal control. In this view it is also conceivable that a relative increase of prefrontal 
inhibition during BAT exposure would have suppressed defense mobilization from the start in low heart rate 
reactive patients (pre-encounter defense). Again, in an exploratory analysis, we also analyzed the relationship 
to other units of analysis, i.e., changes in SCL and reported fear to better understand the regulatory processes 
engaged during this standardized exposure exercise. We assumed associations between heart rate reactivity and 
both vagally controlled HRV and cholinergic sympathetic mediated SCL but considered the different units of 
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analysis to be theoretically neutral in  principle32 with a limited share of common variance due to the specific 
physiological basis.
Method
Participants. We tested defensive reactivity in a subgroup of n = 345 (259 female) PD/AG patients from a 
total sample of n = 369  patients14. 39 patients (11.3%) refused to enter the test chamber (passive avoiders) and, 
thus, could not be included in the analyses of the physiological data. 72 patients (20.9%) entered the test chamber 
but terminated the exposure prematurely (active avoiders). Of these, we could analyze physiological data from 
n = 46 patients (17 patients left the BAT during the very first minute of exposure; 4 patients had to be excluded 
due to cardio-active medications like β-blockers; for 5 patients no valid ECG data were available). Two hundred 
thirty-four patients remained in the test chamber for the entire exposure period. From these patients we could 
analyze physiological data from n = 186 patients (23 patients had to be excluded due to cardio-active medica-
tion; for 25 patients no valid ECG data were available). All included patients (n = 232 (171 female); mean age 
m = 33.9 years; SD = 10.5 years) were Caucasian and free from psychotropic medication.
Patient recruitment, inclusion and exclusion criteria of the overarching clinical trial are described 
 elsewhere28,29 and briefly summarized in the Supplementary Methods. Patient enrollment occurred between 
July 2007 and January 2009. Patients gave written informed consent after receiving a detailed description of the 
study. The study was approved by the Ethics Committee of the Medical Faculty of the Technical University of 
Dresden, which was valid for all participating centers. The experimental procedures performed were in accord-
ance with the relevant guidelines and regulations of the journal.
Experimental stimuli, procedure, and data collection. Following inclusion of the patients, severity 
of psychopathology was evaluated during baseline  assessment29. Patients participated in the BAT in each of the 
eight participating centers following baseline assessment and before treatment. The BAT procedure is described 
in detail  elsewhere14. In short, the BAT consisted of a standardized exposure to a small (75 cm wide, 120 cm long, 
190 cm high), dark and closed test chamber. The BAT consisted of three phases: anticipation (sitting in front 
of the opened test chamber for 10 min), exposure (sitting in the test chamber for an unknown and maximum 
duration of 10 min with the door locked from outside combined with the instruction to stay in the chamber for 
as long as possible but to knock on the door if there is the desire to leave the chamber), and recovery (sitting in 
front of the opened test chamber for 8 min). Intensity of experienced anxiety was assessed by paper and pencil 
after each phase on a 10-point [ranging from 1 (not at all) to 10 (very strong)] scale. Additionally, patients were 
instructed to press a button whenever they experienced a panic attack while being in the chamber and release 
the button as soon as the panic attack was over. Patients always had the opportunity to refuse to participate or to 
stop BAT exposure. Trained investigators immediately supported patients to handle the symptoms experienced 
if necessary.
A personal computer running  VPM33 controlled stimulus presentation, button presses, and physiological 
data acquisition. Bioamplifiers recorded skin conductance level (SCL) and ECG as reported  elsewhere14. In more 
detail, the ECG was recorded with two standard, electrolyte filled Ag/AgCl electrodes (8 mm diameter; Marque-
tte Hellige) placed in an Einthoven Lead II configuration. Using a Coulbourn V75-04 bioamplifier (Allentown, 
PA) the raw signal was filtered online through an 8 to 13 Hz band-pass filter, amplified with the factor 5000 and 
continuously sampled at a rate of 1000 Hz and 100 Hz during the first five minutes of the recovery phase and 
the rest of the assessment, respectively. The output of the panic button press was digitized by an analog to digital 
(A/D) converter (Scientific Solutions, Mentor, Ohio) and recorded as a separate channel with the VPM software.
Data reduction and analysis. After visual inspection of the ECG recordings to detect anomalous signals 
and movement artifacts, misplaced R-wave triggers were corrected whenever they had occurred using ANSLAB 
version 2.4 (Autonomic Nervous System Laboratory, University of Basel, Switzerland) to identify consecutive 
inter beat intervals (IBIs) in milliseconds. Heart rate was computed by converting the IBIs into beats per minute 
per half-second bins, which were averaged by blocks of 10 s. The IBIs were also used for a time domain analysis 
for ultra-short-term heart rate variability. Using an automated script in Stata 16 (StataCorp. 2019. College Sta-
tion, TX: StataCorp LLC.) the root mean square of successive differences (RMSSDs) were calculated for blocks 
of 10 s each. This time window has already been demonstrated to be valid for the quantification of  RMSSD34. 
IBIs corresponding to a mean heart rate below 40 bpm (IBI > 1500 ms) or above 200 bpm (IBI < 300 ms) were 
excluded from analyses. Further, any IBI greater than 10 times the inter quartile range from the median by 
subject were excluded from analyses. To adjust for deviations from a normal distribution and unequal variance, 
RMSSD was logarithmically transformed (natural log).
To control for possible confounding effects of high inter-individual differences within groups we range-
corrected the SCL based on the individual maximum level. Due to missing values SCL data were not available 
in all patients (see figure legends for respective number of included patients). To evaluate the responses evoked 
by the BAT exposure we calculated the relative changes for each minute during the exposure phase relative to 
the mean scores of the recovery for all physiological variables.
To test our hypothesis of decreasing HRV with increasing defensive mobilization in non-avoiding patients, 
those patients who remained in the BAT (n = 186) were subdivided into five groups based on their heart rate reac-
tivity during BAT exposure (heart rate during exposure minus heart rate during recovery) aiming for equivalent 
sample size (n = 37/38 each) within each reactivity group. As illustrated in Table 1 these five heart rate reactivity 
groups did not differ significantly in age, sex, smoking status, BMI, and severity of assessed pathology. To assess 
the influence of vagal control and sympathetic activation on heart rate reactivity during exposure we treated 
these groups as a between-subject variable and tested in a univariate analysis of variance for group differences in 
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changes in RMSSD and SCL during exposure relative to recovery. In this first step, we decided to categorize the 
continuous variable in order to illustrate expected differences in the direction of RMSSD change (decrease vs. 
increase in high vs. low heart rate responders). Due to the possible limited validity of categorizing a continuous 
variable, the group analyses were complemented by correlation and regression analyses in the whole investiga-
tion sample including heart rate, RMSSD, and SCL.
In a second step, we analyzed physiological changes in the group of active avoiders during the first minute of 
exposure and during the last minute prior to active escape from the test chamber to compare autonomic response 
patterns during more proximal and imminent threat and examine it relative to the high heart rate reactive but 
non-avoiding group. Finally, we tested autonomic response patterns during 18 online-recorded panic attacks 
for which physiological data were available during the 10 s block during which panic onset was marked by the 
panic button press and the respective 10 s blocks before and after panic onset. Again, dimensional analyses using 
correlation and regression analyses complemented the group comparisons.
Alpha level was set to 0.05. Greenhouse–Geisser corrections of degrees of freedom were applied whenever 
appropriate.
Ethical approval. The RTC project was approved by the Ethics Committee of the Medical Faculty of the 
Technical University of Dresden (EK 164082006). The neuroimaging components were approved by the Ethics 
Committee of the Medical Faculty of the Rheinisch-Westfälische Hochschule University Aachen (EK 073/07). 
The experimental pharmacology study was approved by the Ethics Committee of the state of Berlin (EudraCT: 
2006-00-4860-29).
Results
Non‑avoiding patients. Heart rate. As intended by group assignment the mean heart rate during the ex-
posure linearly increased from group 1 to group 5 (F(4,181) = 164.19, p < 0.001, ηp2 = 0.78; linear trend: p < 0.001; 
see Fig. 1). Group differences were most pronounced during the first minute and declined during the course of 
exposure (Time × Group F(36,1629) = 10.53, p < 0.001, ηp2 = 0.19; linear trend Time × Group: p < 0.001) but were 
still significant during the last minute (F(4,181) = 45.87, p < 0.001, ηp2 = 0.50).
RMSSD. The five groups also differed significantly in their RMSSD change scores (F(4,181) = 22.36, p < 0.001, 
ηp2 = 0.22; linear trend: p < 0.001; see Fig. 2A). Patients showing the strongest increase in heart rate during expo-
sure (group 5) exhibited the strongest reduction in RMSSD during exposure relative to the recovery period. 
In contrast, patients who showed no increase or even a reduction of heart rate during exposure relative to the 
recovery (group 1 and 2) showed a strong increase in vagal control during exposure which was most pronounced 
at the beginning of exposure. RMSSD differed most strongly between groups during the first minute of BAT 
Table 1.  Distribution of gender, smoking status, age, BMI and symptom severity during baseline assessment 
in the six study groups. Due to missing values, BMI scores, MI Alone scores and smoking status were available 
only for 213 patients (group 1: n = 33; group 2: n = 33; group 3: n = 36; group 4: n = 35; group 5: n = 35; active 
avoiders: n = 41), 211 patients (group 1: n = 36; group 2: n = 34; group 3: n = 34; group 4: n = 33; group 5: n = 34; 
active avoiders: n = 40) and 231 patients (group1: n = 36; group 2: n = 37; group 3: n = 38; group 4: n = 37; 
group 5: n = 37, active avoiders: N = 46), respectively. A patient was classified as a smoker if on average at least 
one unit of tobacco on each day during the last 4 weeks was reported. BMI Body Mass Index, CGI Clinical 
Global Impression Scale, SIGH-A Structured Interview Guide for the Hamilton Anxiety Scale, Number of PA 
number of panic attacks during the last week reported in the Panic and Agoraphobia Scale, MI Alone Mobility 
Inventory, alone subscale.
Heart rate reactivity groups in BAT non-avoiding patients
BAT active avoiding 
patients
1 2 3 4 5
Comparison between 5 
non-avoiding groups
Comparison between 
group 5 and active 
avoiders(n = 37) (n = 37) (n = 38) (n = 37) (n = 37) (n = 46)
n (%)
Women 22 (59.5) 24 (64.9) 25 (65.8) 27 (73) 31 (83.8) 42 (91.3) Chi2(4) = 6.14, p = 0.19 Chi2(1) = 1.09, p = 0.30
Smokers 18 (50) 13 (35.1) 14 (36.8) 20 (54.1) 12 (32.4) 14 (30.4) Chi2(4) = 6.68, p = 0.23 Chi2(1) = 0.04, p = 0.85
Mean (SD)
Age (years) 32.59 (10.11) 35.59 (10.29) 34.92 (11.80) 35.46 (10.58) 33.19 (9.47) 31.76 (10.49) F(4,181) = 0.64, p = 0.64 F(1,81) = 0.41, p = 0.52
BMI (kg/m2) 24.99 (5.14) 24.02 (3.87) 23.14 (3.21) 22.93 (3.60) 23.99 (3.86) 24.58 (5.69) F(4,167) = 1.47, p = 0.21 F(1,74) = 0.26, p = 0.61
CGI (1–7) 5.43 (0.56) 5.30 (0.74) 5.26 (0.69) 5.35 (0.79) 5.27 (0.69) 5.22 (0.66) F(4,181) = 0.38, p = 0.82 F(1,81) = 0.13, p = 0.72
SIGH-A (0–56) 24.30 (4.84) 24.41 (5.61) 24.21 (4.45) 24.65 (5.12) 23.81 (5.64) 25.07 (5.84) F(4,181) = 0.13, p = 0.97 F(1,81) = 0.97, p = 0.33
Number of PA (0–4) 2.76 (2.35) 2.62 (2.61) 2.61 (2.22) 2.05 (2.11) 2.32 (2.27) 2.87 (2.42) F(4,181) = 0.55, p = 0.70 F(1,81) = 1.09, p = 0.29
PAS (0–57) 29.02 (7.69) 28.75 (11.16) 26.37 (11.01) 27.11 (11.03) 26.23 (8.64) 28.95 (8.49) F(4,181) = 0.64, p = 0.64 F(1,81) = 2.06, p = 0.16
MI Alone (1–5) 2.90 (0.75) 2.89 (0.76) 2.83 (0.71) 2.96 (0.98) 2.84 (0.78) 3.09 (0.88) F(4,166) = 0.16, p = 0.96 F(1,72) = 1.64, p = 0.21
BDI-II (0–63) 18.08 (7.39) 15.89 (8.63) 15.03 (8.18) 17.24 (9.10) 17.27 (7.98) 16.76 (8.93) F(4,181) = 0.82, p = 0.52 F(1,81) = 0.07, p = 0.79
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exposure, decreased across exposure (Minute × Group F(36,1629) = 4.43, p < 0.001, ηp2 = 0.09) but were still sig-
nificant during the last minute (F(4,181) = 8.92, p < 0.001, ηp2 = 0.17).
Skin conductance level. SCL also revealed significant group differences (F(4,164) = 11.58, p < 0.001, ηp2 = 0.22), 
with elevated SCL relative to recovery in group five and reduced sympathetic arousal for group one when aver-
aged across the entire exposure relative to recovery (see Fig. 2B). SCL significantly decreased during the course 
of BAT exposure in all five groups indicating a generally strong habituation within this response system (Time 
F(9,1512) = 154.71, p < 0.001, ηp2 = 0.48). Nevertheless, group differences were still significant during the last 
minute of exposure (F(1,4) = 8.37, p < 0.001, ηp2 = 0.17).
Reported fear. Fear ratings during the BAT relative to recovery also differed between groups (F(4,181) = 8.22, 
p < 0.001, ηp2 = 0.15). The highest increase in reported fear was observed in group 5 followed by group 1 (group 
1: m = 2.02, SD = 1.92; group 2: m = 1.17, SD = 1.22; group 3: m = 1.76, SD = 1.42; group 4: m = 1.89, SD = 1.94; 
group 5: m = 3.49, SD = 2.38).
Dimensional analyses. Dimensional analyses confirmed the results of the group comparisons. The overall heart 
rate change during BAT exposure relative to recovery was significantly negatively correlated with the overall 
change in RMSSD (r = − 0.60, p < 0.001), and positively correlated with increases in SCL (r = 0.51, p < 0.001). 
Importantly, changes of the heart rate response from the first minute of exposure to last minute of BAT exposure 
were significantly correlated with changes in the RMSSD across exposure duration (r = − 0.70, p < 0.001) but not 
with changes across time in the SCL, suggesting that changes in vagal control were more important for changes 
in heart rate than changes in sympathetic activation. Stepwise regression analyses confirmed these results with 
changes in RMSSD (beta = − 0.66, p < 0.001; overall ANOVA F(1,167) = 129.53, p < 0.001,  R2 = 0.35) significantly 
predicting changes in heart rate across exposure while changes in SCL did not predict heart rate change during 
exposure.
Imminent threat I: active avoidance. Between-group comparisons. We also analyzed the response dur-
ing BAT exposure in those n = 46 patients showing active avoidance behavior after staying in the test room for at 
least one minute so that RMSSD could be reliably analyzed (mean duration of exposure: 282.37 s, SD = 158.14; 
range: 75–580 s). During the first minute of exposure, active avoiders showed a significant increase of their heart 
rate relative to recovery (m = 10.81, SD = 13.52; F(1,45) = 29.40, p < 0.001, ηp2 = 0.40) which was, however, signifi-
cantly lower as compared to the high reactive group 5 who completed the entire exposure session (see Fig. 1; 
F(1,81) = 6.28, p = 0.01, ηp2 = 0.07). However, active avoiders showed high heterogeneity in heart rate changes 
(range: -5.92 to 41.53 ∆ bpm). The active avoiders also showed a significant reduction of the RMSSD during 
the first minute of exposure relative to the recovery phase (see Fig. 2A; F(1,45) = 3.90, p = 0.05, ηp2 = 0.08) and 
an increase in SCL (see Fig. 2B; F(1,42) = 61.82, p < 0.001, ηp2 = 0.60) but, again, changes were less pronounced 
as compared to completers group 5 (RMSSD: F(1,81) = 3.92, p = 0.05, ηp2 = 0.05; SCL: F(1,75) = 6.18, p = 0.02, 



























Figure 1.  Heart Rate (means and standard errors) during ten minutes of acute threat exposure and averaged 
across the whole threat exposure (embedded figure) relative to a safe condition in n = 186 patients with no 
avoidance behavior during the task as a function of heart rate reactivity groups with increasing heart rate 
responses indicating increasing threat imminence. For comparison the responses during the first minute of 
exposure were also presented for n = 46 patients showing active avoidance but a minimum exposure duration of 
60 s. Heart Rate in bpm, beats per minute.
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In contrast, the relative increase of reported fear was higher in BAT escapers as compared to completers group 5 
(m = 4.69, SD = 2.10; F(1,81) = 5.96, p = 0.02, ηp2 = 0.07).
Autonomic regulatory processes prior to escape. Figure 3 (left column) shows the mean scores and standard 
errors for changes in heart rate, RMSSD, and SCL, during the six last 10 s blocks just prior to escape from the 
test chamber and, for comparison, the first 10 s block at the beginning of BAT exposure. During the respective 
last minute of patients’ BAT exposure we observed a continuous increase of heart rate (F(5,225) = 6.98, p = 0.001, 
ηp2 = 0.13; linear trend: p = 0.001), exceeding the heart rate increase at the beginning of exposure. The course 
of the RMSSD showed a different pattern with an initial increase in RMSSD during the first twenty seconds 


































































Figure 2.  Vagal tone (A) and sympathetic activation (B; means and standard errors) during 10 mins of acute 
threat exposure and averaged across the whole threat exposure (embedded figure) relative to a safe condition 
in n = 186 patients with no avoidance behavior during the task as a function of heart rate reactivity groups with 
increasing heart rate responses indicating increasing threat imminence. For comparison the responses during 
the first minute of exposure were also presented for n = 46 patients showing active avoidance but a minimum 
exposure duration of 60 s. (A) Heart rate variability in logarithmic RMSSD scores, root mean square of 
successive differences. (B) Range corrected skin conductance levels (SCL) in 212 patients with available data.
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prior to escape was significantly negatively correlated with the increase in heart rate (r = − 0.48, p = 0.001). Dif-
ferences in the heart rate responding during first minute of BAT exposure between active avoiders did not affect 
autonomic response patterns during last minute suggesting comparable regulatory processes immediately prior 
escape. However, lower initial heart rate reactivity and associated less pronounced reduction of RMSSD went 
along with higher overall increases of heart rate (r = − 0.45, r = 0.01) and decreases of RMSSD (r = 0.37, p = 0.01) 
from first to respective last minute of BAT exposure suggesting loss of vagal control before switching in circa 
strike defense although control was initially given. To illustrate this autonomic regulatory process on an indi-
vidual level, Fig. 4 shows the course of the inter-beat intervals for one single patient 120 s prior to escape. As can 
be seen in this figure the patient increased vagal control over the heart at the beginning of the exposure session 
but has difficulties to maintain the vagal control after one minute before it completely breaks down 30 s prior to 
escape. As a consequence, inter-beat-intervals linearly decrease 60 s prior to escape. SCL did not change during 










10 sec trial 





Figure 3.  Physiological responses (means and standard errors) during imminent threat relative to a safe 
condition. Left column: The initial 10 s block of acute threat exposure and last six 10 s blocks prior to individual 
active avoidance behavior in n = 46 patients showing active avoidance behavior but a minimum exposure 
duration of 60 s. Right column: The 10 s block including individual panic attack onset and the respective block 
before and after in n = 18 recorded panic attacks. (A) Heart Rate in bpm, beats per minute. (B) Heart rate 
variability in logarithmic RMSSD scores, root mean square of successive differences. (C) Range corrected skin 
conductance levels (SCL). SCL data of 43 patients and 17 panic attacks were available prior active escape and 
during acute panic, respectively.
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the fifty seconds prior to escape but strongly increased during the last 10 s (F(1,42) = 25.19, p < 0.001, ηp2 = 0.38; 
Fig. 3), suggesting that additional sympathetic activation is switched on just before the initiation of defensive 
action. This can also be seen in the individual case where vagal control is almost absent during the last 10 s prior 
to escape with no further increase in heart rate.
Imminent threat II: acute panic. 33 patients reported experiencing a panic attack during BAT exposure. 
Frequency of acute panic was minimal in non-avoiding groups 1 to 3 with almost no increase in heart rate (one 
patient per group), was low in group 4 with moderate increase in heart rate (n = 5, 13.5%) and moderate in group 
5 (n = 9, 24.3%) with the strongest increase in heart rate. The highest frequency of acute panic was observed in 
active avoiders (n = 16, 34.8%; overall: χ2(5) = 31.28, p < 0.001).
We analyzed physiological response patterns in 18 online-recorded panic attacks (see Fig. 3, right column) 
during the 10 s block that included the button press (i.e., the reported onset of the panic attack) and the corre-
sponding blocks before and after the reported onset. Heart rate started to increase prior to the button press and 
continued to rise during the panic attack (linear trend: F(1,17) = 7.20, p = 0.02, ηp2 = 0.30). In contrast, RMSSD 
increased during the onset of the panic attack suggesting an effort for vagal regulation but collapsed during the 
panic attack as demonstrated by a subsequent decrease (quadratic trend: F(1,17) = 8.00, p = 0.01, ηp2 = 0.32). In 
consequence, SCL linearly increased during acute panicking (linear trend: F(1,16) = 7.58, p = 0.01, ηp2 = 0.32).
Discussion
We investigated the interplay between prefrontal inhibitory vagal control and subcortical sympathoexcitatory 
regulation of the heart by re-analysing the physiological data of a group of PD/AG patients when exposed to a 
context in which the probability to experience interoceptive threat is elevated. We used a standardized exposure 
to a situation of entrapment which engages different stages of defensive activation in many—but not all patients 
with PD/AG14. That is why the analyses were based on data covering the entire dimension of threat responding 
along a continuum from safe to imminent threat without including a healthy control group who differ from 
the patient group in many other aspects than the lack of fear of entrapment. From the RDoC perspective our 
reanalysis is a study of the negative valence system as it relates to anticipated threat by physiological symptoms 
arising from inside the body. For these analyses we ranked the patients who remained in this situation for the 
entire period of time according to their heart rate response as an index of autonomic defensive reactivity rela-
tive to baseline into five groups (quintiles) of equal size. We used the average heart rate activity during recovery 
as the baseline because anticipation of the task is already associated with anxiety in some patients. In sum, our 
results confirmed our hypotheses that prefrontal control strongly decreased during clinical entities of circa strike 
defence that are acute panic attacks and active escape in PD/AG patients. Also, we found evidence that prefron-
tal inhibition initially decreased with increasing defensive mobilization in non-avoiding patients but partially 
recovered during BAT exposure. To the best of our knowledge, we have for the first time mapped the dynamics 
Figure 4.  The inter-beat-intervals (IBIs) in ms as a function of time (s) in a single patient 120 s prior to 
escape from the chamber. Variability of IBIs, that is heart rate variability, first increased but then continuously 
decreased starting 60 s after onset of exposure and almost breaks off during the last 20 s prior to escape. The 
length of the IBIs also substantially decreased during this period to an average length of 410 ms, corresponding 
to a heart rate of 146 beats per minute, just prior to escape.
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of prefrontal control in anxiety disordered patients during the in-vivo exposure to a potentially threatening and 
phobic context using phasic changes in vagally mediated HRV.
Increase in vagal control to cope with uncertainty. Supporting our hypotheses, we found a strong 
inverse relationship between changes in heart rate during the exposure task and changes in HRV as an index of 
prefrontal vagal  control24,26 both in the between group comparisons as well as in the dimensional correlation and 
regression analyses. This inverse association was most pronounced at the beginning of the exposure in all groups 
and declined throughout the ten-minute exposure duration. Those patients who showed strong heart accelera-
tion at the beginning of exposure showed a substantial reduction of the RMSSD, suggesting that tonic inhibitory 
vagal control is deactivated when these patients enter a context in which potential interoceptive threat may 
occur. In contrast, those patients who showed even a reduction of their heart rate at the beginning of exposure 
exhibited a significant increase in their RMSSD. These data suggest that these patients actively increased their 
prefrontal inhibitory vagal control to decrease their heart rate during initial exposure. These group differences 
declined throughout the duration of exposure, suggesting that the effort to down-regulate cardiac acceleration 
by prefrontal control is reduced during the course of exposure, probably because patients felt safer in this context 
with no interoceptive threat occurring during the course of time. These findings support the idea put forward 
by Thayer and  others24,35 suggesting that the default response to uncertainty, novelty and potential threat is 
sympathoexcitatory preparation that is inhibited through vagal control via prefrontal activation. According to 
the threat imminence or defense cascade  model5–7 entering such a context in which a potential threat might be 
encountered this chronotropic control of the heart is also accompanied by general hypervigilance to all poten-
tially dangerous cues that—in the case of PD/AG—arise from inside the body.
While changes in RMSSD significantly predicted changes in heart rate, changes in skin conductance did not, 
supporting the notion that vagal control is more prominent for regulating heart rate under these circumstances 
(i.e., pre-encounter defense). We also observed an increase in sympathetic activation particularly at the begin-
ning of the exposure which, however, rapidly declined in all patients during the course of exposure, probably 
reflecting a rapid habituation process to the context. This pattern of autonomic regulation is different for those 
patients who prematurely terminated the exposure, i.e., showing maladaptive active avoidance behaviour.
Collapse of vagal control and sympathetic activation during defensive action. Patients who 
prematurely terminated the exposure showed a linear increase in their heart rate starting already one minute 
before the flight response was activated. RMSSD scores were decreased relative to baseline supporting the view 
that the increase in heart rate was accompanied by reduced vagal control. RMSSD data also showed that patients 
tried to down-regulate their heart rate by enhancing prefrontal vagal control during the first ten seconds of the 
last minute prior active escape, which however, was not successful since heart rate continued to increase during 
this time period. As a result, vagal control decreased again resulting in a further increase in heart rate. Increase 
in sympathetic activation, as indexed by increases in skin conductance level did only occur during the last ten 
seconds just prior to initiation of the flight response. These data suggest that perception of body symptoms that 
seem to get out of control engage an autonomic and behavioural pattern that can best be described as a state 
of circa strike  defense5,6. At the defensive transition zone to circa-strike  threat10 vagal control collapses and 
increased sympathetic activation is switched on to support the effective flight response—in this case leaving the 
chamber as quickly as possible. During this preparation for escape there is also a strong inhibition of the startle 
response to acoustic probe stimuli thus shifting attention to the escape route and blocking the processing of 
irrelevant stimuli in the context of  action14,36,37. Moreover, functional brain imaging data suggest that distributed 
activation shifts from prefrontal areas to midbrain when distal threats become more  proximal38–40. The dynamic 
changes observed in the vagal control of the heart during increasing threat imminence would support these find-
ings. In some patients vagal control seems to be completely blocked during preparation for escape. As compared 
to the high heart rate reactive non-avoiding patients group the reduction of RMSSD was less pronounced in 
active escapers during the first minute of BAT exposure but—in contrast to the non-avoiding patients—further 
increased, especially in those patients with initial high residual control demonstrating the strong dynamic of 
neurovisceral integration in the transition between distal and imminent threat processing.
The autonomic response pattern observed during preparation for escape was remarkably similar to the profile 
observed during spontaneous panic attacks during BAT exposure. Heart rate was accelerated ten seconds prior 
to the button press of reported panic attacks associated with a reduction of RMSSD relative to baseline. While 
heart rate further increased ten seconds after reporting a panic attack, RMSSD increased, suggesting that patients 
again tried to down-regulate their heart rate by increasing vagal control. While heart rate further increased dur-
ing the next ten seconds up to an average of 14 beats per minute, RMSSD decreased again, indicating that vagal 
control of the heart was reduced. Sympathetic activation also increased linearly during the course of a panic 
attack as indicated by a linear increase in the skin conductance level. These data suggest that panic attacks can 
also be considered as an instance of circa strike defense, which are possibly triggered by brainstem circuits. This 
interpretation is supported by early  reports41 showing that electrical stimulation of the PAG evoked acute panic 
attacks in  humans22. Moreover, an increase in activation in the dlPAG during a respiratory challenge causing a 
feeling of dyspnea (inhaling  CO2 enriched air) was  found42. This increase in activation, however was stronger for 
panic disorder patients relative to healthy controls. Interestingly, this activation was reduced in a group of divers 
who have learned to actively cope with such respiratory challenges during their training, probably by recruiting 
prefrontal networks to downregulate the lower brainstem networks. The failure to get access to these networks 
might also increase the sense of losing control during panic attacks.
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Implications for therapy. The current findings might have implications for exposure-based therapies. A 
widely influential model describing the central mechanisms of change involved in exposure based therapies has 
been the emotional processing  theory13,43,44. According to this theory three factors are important mechanisms 
of change, (a) initial fear activation, (b) fear reduction during and c) between exposure sessions. Therefore, it 
seems to be common sense that distraction procedures and safety signals during exposure exercise are often 
viewed as avoidance behaviour and are therefore considered to be counterproductive for these processes. The 
current data, however, suggest that teaching patients techniques to increase their vagal control over the heart 
might increase their capacity to keep prefrontal control over the brainstem systems, particularly during the criti-
cal transition zone from post-encounter to circa strike defense. In addition, using such regulation techniques 
might also induce some sense of control. Indeed, there is some evidence that breathing training might be helpful 
for treating patients with panic  disorder45, however the application of such techniques during critical phases of 
exposure therapy have not been tested yet. First evidence that increased vagal control might be helpful to suc-
cessfully complete exposure therapy comes from a study by Wendt and  coworkers46 showing that higher cardiac 
vagal control prior to treatment reduced exposure treatment dropout in PDA patients. Thus, training of such 
“physiological regulation strategies” might increase prefrontal control and might increase inhibition of fear in 
such exposure contexts. First evidence from the laboratory that increased resting heart rate variability enhances 
inhibition of conditioned fear are  promising47,48.
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